17-30325071-C-T
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_206832.3(TMIGD1):c.385G>A(p.Asp129Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00008 in 1,613,174 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_206832.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TMIGD1 | NM_206832.3 | c.385G>A | p.Asp129Asn | missense_variant | 4/7 | ENST00000328886.5 | NP_996663.1 | |
TMIGD1 | NM_001319942.2 | c.385G>A | p.Asp129Asn | missense_variant | 4/6 | NP_001306871.1 | ||
TMIGD1 | XM_011524787.2 | c.385G>A | p.Asp129Asn | missense_variant | 4/7 | XP_011523089.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TMIGD1 | ENST00000328886.5 | c.385G>A | p.Asp129Asn | missense_variant | 4/7 | 1 | NM_206832.3 | ENSP00000332404 | P1 | |
TMIGD1 | ENST00000538566.6 | c.385G>A | p.Asp129Asn | missense_variant | 4/6 | 2 | ENSP00000446118 |
Frequencies
GnomAD3 genomes AF: 0.0000526 AC: 8AN: 152126Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000319 AC: 8AN: 250930Hom.: 0 AF XY: 0.0000442 AC XY: 6AN XY: 135672
GnomAD4 exome AF: 0.0000828 AC: 121AN: 1461048Hom.: 0 Cov.: 31 AF XY: 0.0000949 AC XY: 69AN XY: 726760
GnomAD4 genome AF: 0.0000526 AC: 8AN: 152126Hom.: 0 Cov.: 32 AF XY: 0.0000538 AC XY: 4AN XY: 74300
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 17, 2021 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at